Patient summary
Polycystic ovarian syndrome (PCOS) is a relatively common condition. Women who have PCOS have an increased risk of diabetes and a range of other significant health problems which can be exacerbated by being overweight or obese. Because of this, women with PCOS should maintain a healthy lifestyle including managing any mental health problems. Life-long strategies should be in place to detect, and manage conditions such as diabetes, hypertension, and high cholesterol.
Summary of recommendations

Recommendation 1 Grade and reference
The most commonly accepted consensus criteria for diagnosis of PCOS are the "Rotterdam" criteria. 6 The Rotterdam criteria include a number of phenotypes of PCOS, including mild phenotypes that would be excluded by previous criteria.
Consensus-based recommendation 6 Recommendation 2
Grade and reference PCOS should not be over-diagnosed, and diagnosis should be in strict accordance with current international criteria. It is likely that high values of AMH will become an important diagnostic criterion in place of ultrasound.
Consensus-based recommendation
Recommendation 3 Grade and reference
Women with PCOS, particularly if they are overweight (BMI>30kg/m2) are at increased risk of impaired glucose tolerance (IGT), Type 2 Diabetes (T2D) and metabolic syndrome. Metabolic dysfunction in PCOS should be investigated and managed.
Consensus-based recommendation
Recommendation 4 Grade and reference
Fasting glucose levels are poor predictors of glucose intolerance risk in women with PCOS and therefore screening for IGT should be by a 2-hour oral glucose tolerance test (OGTT). However, there is no current consensus on who should be screened.
Consensus-based recommendation
Reference 10
Recommendation 5 Grade and reference
Consideration should be given to repeat screening based on the key predictors for the development of diabetes: age, BMI, family history. Measurement of insulin levels is not recommended as it has little practical utility in PCOS.
Consensus-based recommendation
References 4, 5
Recommendation 6 Grade and reference
Women with PCOS should be screened for cardiovascular risk by determination of BMI, fasting lipid and lipoprotein levels and metabolic syndrome risk factors.
Consensus-based recommendation
Reference 5
Recommendation 7
Grade and reference Almost every study of PCOS has shown a higher risk of depression, anxiety and worsened quality of life in this condition. Practitioners must investigate the presence of mental distress and include treatment of this in the management plan.
Consensus-based recommendation
Reference 15
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Reference 31
Recommendation 17 Grade and reference
Pregnancy when obese is associated with many increased risks therefore it is inappropriate to recommend ovarian stimulation as part of first line therapy in the female with a BMI >35 unless there are exceptional circumstances.
Consensus-based recommendation
Long term health consequences of PCOS C-Gyn 26 5
Introduction
Polycystic ovarian syndrome (PCOS) is the most common endocrine abnormality in women of reproductive age. It may be associated with anovulation, infertility, hyperandrogenism, and long-term metabolic sequelae. Insulin resistance is central to this syndrome, driving increased androgen levels and resulting in impaired glucose tolerance and, potentially, an increase in cardiovascular disease.
The prevalence of PCOS is estimated conservatively at 6-7 per cent of the population(or 400,000 Australian women) 1 but recent studies from the Robinson Institute in Adelaide suggest a much higher prevalence 2 especially in the Aboriginal population. 3 Obesity aggravates insulin resistance, and as obesity in the community increases, the prevalence of, and complications from, PCOS are expected to rise.
Women with PCOS should be fully informed about the long-term health consequences of this condition, and advised about how they may reduce their risk.
4.
Evidence summary and basis for recommendations
How is PCOS diagnosed?
The diagnostic criteria for PCOS remain unresolved. However, all diagnostic approaches require that secondary causes (adult onset congenital adrenal hyperplasia, hyperprolactinaemia, and androgen secreting neoplasms) should first be excluded. 4, 5 Currently, the most commonly accepted consensus criteria for diagnosis of PCOS are the "Rotterdam" criteria, 6 agreed by ESHRE and ASRM. The NIH has recently affirmed the paramount value of the Rotterdam criteria. 7 The Rotterdam criteria require two of the three following for the diagnosis of PCOS:
 Polycystic ovaries (either 12 or more peripheral antral follicles or increased ovarian volume).  Oligomenorrhea or anovulation.  Clinical and/or biochemical signs of hyperandrogenism.
The Rotterdam criteria will include a number of phenotypes of PCOS, including mild phenotypes that would be excluded by previous criteria. PCOS should not be over-diagnosed, and diagnosis should be in strict accordance with current international criteria. It is likely that high values of AMH will become an important diagnostic criterion in place of ultrasound.
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What are the metabolic consequences of PCOS?
Women with PCOS, particularly if they are overweight (BMI>30kg/m 2 ) are at increased risk of impaired glucose tolerance (IGT), Type 2 Diabetes (T2D) and metabolic syndrome ( Table 1) . The investigation and management of metabolic dysfunction in PCOS is therefore of prime importance. A study of a large cohort of Australian women with PCOS 1 revealed an incidence of IGT of 15.6% and T2D of 4%. Most women in this study were also obese with a mean BMI of 35kg/m 2 . Although obesity exacerbates insulin resistance, women with PCOS are insulin resistant independent of obesity. Lean women with PCOS have a 2-fold increase in incidence of T2D compared to controls. 8 Women with PCOS are also at increased risk of gestational diabetes (OR 2.94). 9 Fasting glucose levels are poor predictors of glucose intolerance risk in women with PCOS and therefore screening for IGT should be by a 2-hour oral glucose tolerance test (OGTT). 10 However, there is no current consensus on who should be screened. Some authorities recommend that all women diagnosed with PCOS should be screened with a 2-hour oral glucose tolerance test. 5 Others recommend that an OGTT should be given to women with a fasting blood sugar of 5.6mmol/l or greater, BMI greater than 30kg/m 2 , a strong family history of gestational diabetes 4 , or lean PCOS women of advanced age (>40years). 11 Currently both strategies appear to be acceptable.
Longitudinal studies have also confirmed an increased incidence of T2D over time, 12 and conversion from IGT to T2D. 13 Consideration should be given to repeat screening 5 based on the key predictors for the development of diabetes: age, BMI, family history. Measurement of insulin levels has little practical utility in PCOS and is not recommended. 4, 5 There is increasing recognition of the metabolic syndrome as a risk for the development of cardiovascular disease. This syndrome is increasingly common in Western societies, and the prevalence in women with PCOS has been found to be up to 45 per cent . 14 Women with PCOS should be screened for cardiovascular risk by determination of BMI, fasting lipid and lipoprotein levels and metabolic syndrome risk factors. 5 
Recommendation 1
Grade and reference
Consensus-based recommendation Reference 6
Recommendation 2
Consensus-based recommendation
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4.3 What are other risks associated with PCOS?
Emotional and quality of life issues
Almost every study of PCOS has shown a higher risk of depression, anxiety and worsened quality of life in this condition. Practitioners must investigate the presence of mental distress and include treatment of this in the management plan. The impact of impaired quality of life on long-term health can be imputed but has not been measured. 
Consensus-based recommendation
Recommendation 4 Grade and reference
Consensus-based recommendation
Recommendation 5 Grade and reference
Consensus-based recommendation
Recommendation 6 Grade and reference
Consensus-based recommendation
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Cardiovascular risk
Prospective studies have not as yet identified an increase in cardiac events in women with PCOS. 16 However, there is indirect evidence of increased cardiovascular risk. The Nurses' Health Study has revealed an increasing risk of cardiovascular disease with increasing oligomenorrhea. 17 Studies in premenopausal women with PCOS have also revealed an increase in sub-clinical atherosclerosis compared to controls. 18, 19 Hypertension should be actively treated in women with PCOS, but as yet there is insufficient evidence to recommend routine treatment with lipid lowering drugs such as statins. 4 Women diagnosed with PCOS should be strongly advised to refrain from smoking.
Obstructive sleep apnoea
Obstructive sleep apnoea (OSA) is an independent risk factor for cardiovascular disease and is more common in PCOS. The difference in prevalence of OSA between PCOS and controls remains significant even when controlling for BMI. 20, 21 Women diagnosed with PCOS should be asked about the symptoms of OSA (snoring, daytime fatigue/somnolence) and offered investigation and treatment if indicated.
Cancer
Obesity, which is common in PCOS, is a recognised risk factor for several different cancers. It is also well recognised that oligomenorrhea or amenorrhea in women with PCOS may pre-dispose to endometrial hyperplasia and carcinoma. 22 Women with oligomenorrhea or irregular bleeding should be investigated according to local protocols. This may involve trans-vaginal assessment of Recommendation 7 Grade and reference Almost every study of PCOS has shown a higher risk of depression, anxiety and worsened quality of life in this condition. Practitioners must investigate the presence of mental distress and include treatment of this in the management plan.
Consensus-based recommendation
Recommendation 8 Grade and reference
Hypertension should be actively treated in women with PCOS, but as yet there is insufficient evidence to recommend routine treatment with lipid lowering drugs such as statins.
Consensus-based recommendation
Reference 4
Recommendation 9 Grade and reference
Women diagnosed with PCOS should be strongly advised to refrain from smoking.
Consensus-based recommendation
Recommendation 10 Grade and reference
Women diagnosed with PCOS should be asked about the symptoms of OSA (snoring, daytime fatigue/somnolence) and offered investigation and treatment if indicated.
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How can PCOS be treated?
Lifestyle prevention
Lifestyle intervention through diet and exercise are the key treatments for reducing risk in PCOS. Women with PCOS who are not obese, should be strongly advised to maintain their BMI in the normal range. Modest weight reduction (5-10%) is associated with a significant improvement in metabolic indices. 24 Dietary advice should focus on total calorific intake, and on the balance of evidence, low glycaemic index diets are preferred. 25 Regular exercise (30 minutes of aerobic exercise/day) has been shown to decrease central obesity and increase insulin sensitivity and is therefore strongly recommended.
26 Women diagnosed with PCOS should be advised of the longterm health benefits of maintaining a healthy lifestyle.
Drug therapy
Insulin sensitising agents such as metformin have a role when IGT or T2D has been diagnosed. However, there is no current evidence indicating that these drugs lower cardiovascular risk, and their routine use in PCOS is not recommended. 4, 5, 10 Trials suggest that metformin is not superior to lifestyle intervention in improving cardio-metabolic risk or progression to T2D. 27, 28 Cholesterol lowering drugs should be reserved for women with PCOS proven to have dyslipidaemia. Treatment of elevated blood pressure is important for decreasing the risk of cardiovascular disease and antihypertensive medication should be prescribed if lifestyle modifications are ineffective at controlling blood pressure. 11 
Recommendation 11
Lifestyle intervention through diet and exercise are the key treatments for reducing risk in PCOS. Regular exercise (30 minutes of aerobic exercise/day) has been shown to decrease central obesity and increase insulin sensitivity and is therefore strongly recommended.
Consensus-based recommendation
References 24, 25, 26 Recommendation 12 Grade and reference
The routine use of insulin sensitising agents such as metformin in PCOS is not recommended.
References 4, 5, 10
Recommendation 13 Grade and reference
Cholesterol lowering drugs should be reserved for women with PCOS proven to have dyslipidaemia.
Consensus-based recommendation
Recommendation 14
Grade and reference Treatment of elevated blood pressure is important for decreasing the risk of cardiovascular disease and antihypertensive medication should be prescribed if lifestyle modifications are ineffective at controlling blood pressure.
Consensus-based recommendation
Reference 11
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Bariatric Surgery
Bariatric surgery has been shown to be effective in women with PCOS and may be an option for severely obese women with PCOS in whom long-term diet-based strategies are seldom successful. 29, 30 Surgical induced weight loss, however must be balanced against the risks of surgery, including a 0.1-1% mortality, risk of bowel obstruction, infection, esophagitis and nutritional abnormalities. 29 Bariatric surgery should be performed only when standard weight loss regimes have failed in PCOS women with a BMI greater than 40kg/m 2 or greater then 35kg/m 2 with a high-risk obesity related condition. 31 
Ovulation induction
Randomised trials suggest that clomiphene is the first line treatment and more effective than metformin alone for ovulation induction in PCOS.
However, pregnancy when obese is associated with many increased risks therefore it is inappropriate to recommend ovarian stimulation as part of first line therapy in the female with a BMI >35 unless there are exceptional circumstances. 32 
Recommendation 15
Bariatric surgery has been shown to be effective in women with PCOS and may be an option for severely obese women with PCOS in whom long-term dietbased strategies are seldom successful.
Consensus-based recommendation References 29, 30 Recommendation 16
Grade and reference Bariatric surgery should be performed only when standard weight loss regimes have failed in PCOS women with a BMI greater than 40kg/m2 or greater then 35kg/m2 with a high-risk obesity related condition.
Consensus-based recommendation
Recommendation 17 Grade and reference
Consensus-based recommendation
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5.
Links to other College statements 
